Nitric oxide, oxidative stress, and apoptosis

Kidney International, Supplement

Volumn 63, Issue 84, 2003, Pages

  Brüne, Bernhard ^a   Zhou, Jie ^a   Von Knethen, Andreas ^a  

^a Rheinland Pfälzische Technische Universität Kaiserslautern Landau   (Germany)

Author keywords

Apoptosis; Hypoxia inducible factor 1 ; Nitric oxide; p53; Superoxide; Survival

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; NITRIC OXIDE; OXIDIZED LOW DENSITY LIPOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN P53; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; TRANSCRIPTION FACTOR;

APOPTOSIS; ATHEROGENESIS; CELL COMMUNICATION; CELL FUNCTION; COMPLEX FORMATION; CONFERENCE PAPER; HUMAN; MACROPHAGE; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN STABILITY; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; KIDNEY DISEASE; METABOLISM; PHYSIOLOGY; REVIEW;

APOPTOSIS; HUMANS; KIDNEY DISEASES; NITRIC OXIDE; OXIDATIVE STRESS;

EID: 0037406379     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.63.s84.6.x     Document Type: Conference Paper

References (14)

1. GLASS CK, WITZTUM JL: Atherosclerosis: The road ahead. Cell 104:503-516, 2001
2. CAI H, HARRISON DG: Endothelial dysfunction in cardiovascular diseases: The role of oxidant stress. Circ Res 87:840-844, 2000
3. MICHALIK L, WAHLI W: Peroxisome proliferator-activated receptors: Three isotypes for a multitude of functions. Curr Opin Biotechnol 10:564-570, 1999
4. FISCHER B, VON KNETHEN A, BRÜNE B: Dualism of oxLDL in provoking and attenuating the oxidative burst in macrophages: Role of PPARγ. J Immunol 168:2828-2834, 2002
5. VON KNETHEN A, BRÜNE B: Delayed activation of PPARγ in macrophages by LPS and IFN-γ attenuates the oxidative burst. FASEB J 15:535-544, 2001
6. phox and attenuates the respiratory burst. J Immunol 169:2619-2626, 2002
7. HEINLOTH A, BRÜNE B, FISCHER B, GALLE J: Nitric oxide prevents oxidized LDL-induced p53 accumulation and cytochrome c translocation and apoptosis in macrophages via guanylate cyclase stimulation. Atherosclerosis 162:93-101, 2002
8. SEMENZA GL: HIF-1 and tumor progression: Pathophysiology and therapeutics. Trends in Mol Med 8:S62-S67, 2002
9. BRÜNE B, VON KNETHEN A, SANDAU KB: Transcription factors p53 and HIF-1α as targets of nitric oxide. Cell Signal 13:525-533, 2001
10. SANDAU KB, FANDREY J, BRÜNE B: Accumlation of HIF-1α under the influence of nitric oxide. Blood 97:1009-1015, 2001
11. SANDAU KB, ZHOU J, KIETZMANN T, BRÜNE B: Regulation of the hypoxia-inducible-factor 1α by the inflammatory mediators nitric oxide and tumor necrosis factor-α in contrast to desferroxamine and phenylarsine oxide. J Biol Chem 276:39805-39811, 2001
12. GRISHAM MB, JOURD'HEUL D, WINK DA: Nitric oxide: Physiological chemistry of nitric oxide and its metabolites, implications in inflammation. Am J Physiol 276:G315-G321, 1999
13. BRÜNE B: Nitric oxide (NO) and apoptosis in mesangial cells. Kidney Int 61:786-789, 2002
14. SUMBAYEV V, SANDAU KB, BRÜNE B: Mesangial cells but not Hep G2 hepatocytes are protected towards nitric oxide/superoxide cogeneration: Mechanistic considerations. Eur J Pharmacol 444:1-11, 2002